AbCellera to present Phase 2 data on menopause drug at IMS congress

September 16, 2026 4:05 PM

AbCellera Biologics (Nasdaq: ABCL) announced it will present Phase 2 data on its investigational drug ABCL635 at the International Menopause ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found